First Time Loading...

Alpine Immune Sciences Inc
NASDAQ:ALPN

Watchlist Manager
Alpine Immune Sciences Inc Logo
Alpine Immune Sciences Inc
NASDAQ:ALPN
Watchlist
Price: 64.95 USD
Updated: May 15, 2024

EV/EBITDA
Enterprise Value to EBITDA

-77.8
Current
-4.1
Median
4.3
Industry
Lower than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-77.8
=
Enterprise Value
4B
/
EBITDA
-50.8m
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
-32.4
2-Years Forward
EV/EBITDA
-26.6
3-Years Forward
EV/EBITDA
-23.7

See Also

Discover More